Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Online Obesity Treatment in Primary Care (Rhode Island, USA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03488212
Recruitment Status : Not yet recruiting
First Posted : April 4, 2018
Last Update Posted : April 4, 2018
Sponsor:
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by (Responsible Party):
John Graham Thomas, The Miriam Hospital

Brief Summary:
Behavioral obesity treatment produces clinically significant weight loss; for the greatest impact, it should be made available in the primary care setting where it can reach the many patients with overweight/obesity. The investigators developed a 3-month automated online behavioral weight loss program, Rx Weight Loss (RxWL), and showed that it produces clinically significant weight losses among primary care patients. The investigators' early efforts at pragmatic implementation of RxWL have been promising, and have shed light on challenges associated with implementation, and the need to study longer-term effectiveness. The investigators will therefore conduct a pragmatic study to improve the implementation and effectiveness of this behavioral obesity intervention delivered in routine and representative healthcare settings. The investigators are partnering with the Rhode Island Primary Care Physicians Corporation (RIPCPC), a large primary care network of 58 practices with 100 physicians and 16 nurse care managers. Using the framework for Effectiveness-Implementation Hybrid Designs, the investigators will simultaneously target effectiveness and implementation to maximize the public health impact of the research. Half of the 16 nurse care managers, and the practices they serve, will be randomized to either Basic Implementation (alerts generated using the electronic medical record [EMR] to direct eligible patients to RxWL), or to the Enhanced Implementation (alerts, clinician skills training to motivate and support weight loss, clinician dashboard with reports on patient progress and tools to facilitate patient engagement and behavior change). The investigators will test the hypothesis that the Enhanced Implementation will increase the proportion of patients directed to, enrolling, and completing the weight loss program. Because maintenance of weight loss is a critical problem, this project will also involve randomization of 600 patients with overweight/obesity and type 2 diabetes, hypertension, and/or hypercholesterolemia to the 3 month RxWL intervention followed by one of three maintenance conditions: (a) Control- 9 monthly online education sessions; (b) Monthly Lessons and Feedback- 9 monthly online video lessons teaching self-regulation with automated feedback on the self-monitoring record; (c) Refresher Campaigns- 9 monthly on-line video sessions, teaching self-regulation and providing two 4-week courses with novel strategies and behavioral challenges to improve long-term outcomes. The investigators will test the hypothesis that 12-month weight losses are better with Refresher Campaigns than Monthly Lessons and Feedback, and both are better than Control. Secondary outcomes include changes in weight, CVD risk factors, and medication use over a full 24 months. The project is significant and innovative because: it uses an empirically validated approach to obesity treatment that is integrated into the primary care setting, leveraging existing staff and EMR capabilities; it has a dual focus on improving effectiveness and implementation; it has a pragmatic design in partnership with a large primary care network that treats a diverse patient population; and it has potential to it provides a scalable, sustainable approach that can serve as a model for broader dissemination of obesity treatment intervention.

Condition or disease Intervention/treatment Phase
Overweight and Obesity Behavioral: Training to Identify Eligible Patients and Direct them to Online Obesity Treatment Program Behavioral: Training to Motivate and Support Patients' Weight Loss Behavioral: Online Behavioral Weight Loss Intervention Behavioral: Control Intervention for Weight Loss Maintenance and Weight Gain Prevention Behavioral: Monthly Lessons and Feedback Intervention for Weight Loss Maintenance and Weight Gain Prevention Behavioral: Refresher Courses for Weight Loss Maintenance and Weight Gain Prevention Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 600 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Investigator)
Primary Purpose: Treatment
Official Title: Pragmatic Trial of Technology-Supported Behavioral Obesity Treatment in the Primary Care Setting: A Multiphase Effectiveness and Implementation Hybrid Design
Estimated Study Start Date : April 9, 2018
Estimated Primary Completion Date : April 30, 2021
Estimated Study Completion Date : April 30, 2021

Arm Intervention/treatment
Active Comparator: Basic Implementation Intervention Behavioral: Training to Identify Eligible Patients and Direct them to Online Obesity Treatment Program
Primary care clinic staff are trained to identify patients who meet study inclusion and exclusion criteria. They are then trained to provide patients with the information necessary to enroll in the study and access the online behavioral obesity treatment.

Experimental: Enhanced Implementation Intervention Behavioral: Training to Identify Eligible Patients and Direct them to Online Obesity Treatment Program
Primary care clinic staff are trained to identify patients who meet study inclusion and exclusion criteria. They are then trained to provide patients with the information necessary to enroll in the study and access the online behavioral obesity treatment.

Behavioral: Training to Motivate and Support Patients' Weight Loss
Primary care clinic staff are trained in psychological and behavioral strategies for: talking to patients about weight and weight loss in a way that patients find acceptable and helpful, increasing motivation for weight loss, overcoming common barriers to weight loss, and persevering with a weight loss attempt. They are trained in strategies to provide this support by telephone in addition to during clinic visits.

Active Comparator: Online Treatment; Control Maintenance Intervention Behavioral: Online Behavioral Weight Loss Intervention
For 3 months, participants receive: a weekly online lessons for training in behavioral skills for losing weight; online self-monitoring of daily weight, diet, and physical activity; weekly feedback on the self-monitoring record.

Behavioral: Control Intervention for Weight Loss Maintenance and Weight Gain Prevention
After completing the 3-month Online Behavioral Weight Loss Intervention, participants receive 9 months of: monthly online newsletters with educational information pertaining to healthy weight, diet, and physical activity habits.

Experimental: Online Treatment; Monthly Lessons & Feedback for Maintenance Behavioral: Online Behavioral Weight Loss Intervention
For 3 months, participants receive: a weekly online lessons for training in behavioral skills for losing weight; online self-monitoring of daily weight, diet, and physical activity; weekly feedback on the self-monitoring record.

Behavioral: Monthly Lessons and Feedback Intervention for Weight Loss Maintenance and Weight Gain Prevention
After completing the 3-month Online Behavioral Weight Loss Intervention, participants receive 9 months of: monthly online lessons for training in behavioral skills for maintaining weight loss and preventing weight gain; online self-monitoring of daily weight, diet, and physical activity; monthly feedback on the self-monitoring record.

Experimental: Online Treatment; Refresher Courses for Maintenance Behavioral: Online Behavioral Weight Loss Intervention
For 3 months, participants receive: a weekly online lessons for training in behavioral skills for losing weight; online self-monitoring of daily weight, diet, and physical activity; weekly feedback on the self-monitoring record.

Behavioral: Refresher Courses for Weight Loss Maintenance and Weight Gain Prevention
After completing the 3-month Online Behavioral Weight Loss Intervention, participants receive two month-long refresher courses with weekly online lessons for training in behavioral skills for maintaining weight loss and preventing weight gain; online self-monitoring of daily weight, diet, and physical activity; weekly feedback on the self-monitoring record; weekly challenges focuses on specific behavior change and weight loss goals.




Primary Outcome Measures :
  1. Change in Weight [ Time Frame: 12 months after study enrollment ]

Secondary Outcome Measures :
  1. Change in Weight [ Time Frame: 24 months after study enrollment ]
  2. Proportion of Patients Achieving a Weight Loss of ≥5% of Initial Body Weight [ Time Frame: 12 and 24 months after study enrollment ]
  3. Patient Satisfaction with the Treatment Program [ Time Frame: 3 and 12 months after study enrollment ]
    Using a questionnaire developed for this study, patients are asked to rate their overall satisfaction with the treatment program, specific components of the treatment program, and the likelihood that they would recommend the program to family and friends, on a 5-point Likert scale ranging from 1 (Low) to 5 (High).

  4. Provider Satisfaction with the Treatment Program [ Time Frame: 12 months after study enrollment ]
    Using a questionnaire developed for this study, providers are asked to rate their overall satisfaction with the treatment program, and specific components of the treatment program, on a 5-point Likert scale ranging from 1 (Low) to 5 (High).

  5. Proportion of Patients Deemed Eligible by the Electronic Medical Record Who are Directed to the Online Treatment Program [ Time Frame: 24 months after study initiation ]
    The proportion of patients who approached by clinic staff for potential participation in the study, out of the patients who are deemed potentially eligible in reports generated using the electronic medical record.

  6. Proportion of Patients That Enroll After Being Directed to the Online Treatment Program [ Time Frame: 24 months after study initiation ]
    The proportion of patients who enroll in the study out of the patients who are approached by clinic staff for potential participation in the study.

  7. Proportion of Enrolled Patients who Complete the Online Treatment Program [ Time Frame: 24 months after study initiation ]
    The proportion of patients who complete the initial 3-month weight loss treatment and following 9-month weight loss maintenance and weight gain prevention program, out of those that enroll.

  8. Clinician Contact with Patients Directed to the Online Treatment Program [ Time Frame: 24 months after study initiation ]
    Number and type of clinician contact with patients (e.g., clinic visits, phone calls).

  9. Patient Engagement and Adherence to the Online Intervention. [ Time Frame: 12 months after study enrollment ]
    The online treatment platform automatically records all aspects of use including logins, lessons viewed, and self-monitoring records submitted.

  10. Clinician Engagement with the Online Treatment Platform [ Time Frame: 24 months after study initiation ]
    Frequency and type of use (e.g., viewing patients progress metrics) of the online platform for tracking patient progress in the online treatment.

  11. Change in Low-density Lipoprotein (mg/dL) [ Time Frame: 12 and 24 months after study enrollment ]
  12. Change in High-density Lipoprotein (mg/dL) [ Time Frame: 12 and 24 months after study enrollment ]
  13. Change in Triglycerides (mg/dL) [ Time Frame: 12 and 24 months after study enrollment ]
  14. Change in Blood Glucose (mg/dL) [ Time Frame: 12 and 24 months after study enrollment ]
  15. Change in Glycated Haemoglobin (HbA1c) [ Time Frame: 12 and 24 months after study enrollment ]
  16. Change in Systolic Blood Pressure (mmHG) [ Time Frame: 12 and 24 months after study enrollment ]
  17. Change in Diastolic Blood Pressure (mmHG) [ Time Frame: 12 and 24 months after study enrollment ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Body mass index (BMI) between 25-45 kg/meters-squared
  • one or more cardiovascular risk factor (type 2 diabetes, hypercholesterolemia, or hypertension)

Exclusion Criteria:

  • currently in another active weight loss program
  • taking weight loss medication
  • currently pregnant, lactating
  • <6 months post-partum
  • plan to become pregnant during the next 12 months
  • a medical condition that would affect the safety of participating in unsupervised physical activity
  • inability to walk 2 blocks without stopping

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03488212


Contacts
Layout table for location contacts
Contact: Graham Thomas, PhD 401-793-8154 jthomas4@lifespan.org
Contact: Rena R Wing, PhD 401-793-8950 rwing@lifespan.org

Sponsors and Collaborators
The Miriam Hospital
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Investigators
Layout table for investigator information
Principal Investigator: Graham Thomas, PhD The Miriam Hospital
Principal Investigator: Rena R Wing, PhD The Miriam Hospital

Layout table for additonal information
Responsible Party: John Graham Thomas, Associate Professor (Research), The Miriam Hospital
ClinicalTrials.gov Identifier: NCT03488212     History of Changes
Other Study ID Numbers: R18DK114715 ( U.S. NIH Grant/Contract )
R18DK114715 ( U.S. NIH Grant/Contract )
First Posted: April 4, 2018    Key Record Dates
Last Update Posted: April 4, 2018
Last Verified: March 2018
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Obesity
Overweight
Overnutrition
Nutrition Disorders
Body Weight
Signs and Symptoms